ARCHIVES

To Become Effective Lobbyists, Scientists Seek Alliances With Patient Advocates

This article is from The Cancer Letter archive.

Vol. 21 No. 13 | March 31, 1995

Download PDF Visit The Full Archive

Related Articles

In Brief: NCI To Move Todaro’s Lab to FCR; Cinnamyl Anthranilate Was Carciogenic In Bioassay

March 28, 1980

Von Eschenbach Presents His “2015 Goal” As Logical Progression of Cancer Program (Interview)

May 16, 2003

GAO Decision Clears NCI to Deploy Medidata Rave Data Capture System

June 17, 2011

DCT Board Approves $8 Million In Contract Projects For Recompetition

October 31, 1980

Interferon Interest Zooms; NCI Awarding Production Contracts, Proceeds With Plans For Clinical Trials

March 14, 1980

Letter: The Lesson From Dana-Farber

July 28, 1995